IL6 and COVID-19: It is notable that in our study, easily accessible biomarkers (i.e., ferritin, fibrinogen) showed comparative performance with IL-6 and some of the blood-based biomarkers tested for post-acute COVID-19, while for 30-day mortality, outperformed Il-6 (i.e., NLR, MLR, hs-CRP).